European Society for Medical Oncology

Organization

Publications in OpenAlex of which a co-author is affiliated to this organization

All publications | By field | By subfield

All publications [Next]
Title DOI
https://doi.org/10.1136/esmoopen-2018-000372 Indicators of integration at ESMO Designated Centres of Integrated Oncology and Palliative Care
https://doi.org/10.1093/annonc/mdy064 The hard road to data interpretation: 3 or 6 months of adjuvant chemotherapy for patients with stage III colon cancer?
https://doi.org/10.15190/d.2019.2 Therapy-induced cardiotoxicity in breast cancer patients: a well-known yet unresolved problem
https://doi.org/10.1002/ejhf.422 Cell-Based Therapies for Cardiac Repair: A Meeting Report on Scientific Observations and European Regulatory Viewpoints
https://doi.org/10.1093/annonc/mdu218 Risks of the new EU Data protection regulation: an ESMO position paper endorsed by the European oncology community
https://doi.org/10.1016/j.ejca.2017.04.014 Identifying critical steps towards improved access to innovation in cancer care: a European CanCer Organisation position paper
https://doi.org/10.15829/1560-4071-2017-3-145-154 MODERN VIEW ON CARDIOTOXICITY OF CHEMOTHERAPEUTICS IN ONCOLOGY INCLUDING ANTHRACYCLINES
https://doi.org/10.1097/jto.0b013e3182a46bcf Health-Related Quality of Life in Patients with Advanced Nonsquamous Non–Small-Cell Lung Cancer Receiving Bevacizumab or Bevacizumab-Plus-Pemetrexed Maintenance Therapy in AVAPERL (MO22089)
https://doi.org/10.1136/esmoopen-2017-000187 Safeguarding the future of independent, academic clinical cancer research in Europe for the benefit of patients
https://doi.org/10.1016/j.annonc.2020.12.015 Access to essential anticancer medicines for children and adolescents in Europe
https://doi.org/10.1016/j.esmoop.2021.100304 Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with renal cell carcinoma
https://doi.org/10.1016/j.esmoop.2022.100499 COVID-19 in patients with cancer: first report of the ESMO international, registry-based, cohort study (ESMO-CoCARE)
https://doi.org/10.1200/go.20.00632 Impact of Strategies for Mitigating Delays and Disruptions in Cancer Care Due to COVID-19: Systematic Review
https://doi.org/10.1136/esmoopen-2017-000216 Detailed statistical assessment of the characteristics of the ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) threshold rules
https://doi.org/10.1136/esmoopen-2018-000467 Care of adolescents and young adults with cancer in Asia: results of an ESMO/SIOPE/SIOP Asia survey
https://doi.org/10.1016/j.annonc.2023.06.002 ESMO-Magnitude of Clinical Benefit Scale for haematological malignancies (ESMO-MCBS:H) version 1.0
https://doi.org/10.3233/978-1-61499-781-8-19 CrowdHEALTH: Holistic Health Records and Big Data Analytics for Health Policy Making and Personalized Health
https://doi.org/10.1016/j.ijmedinf.2022.104860 Medical informatics and digital health multilingual ontology (MIMO): A tool to improve international collaborations
https://doi.org/10.1136/esmoopen-2019-000662 ESMO Clinical Research Observatory (ECRO): improving the efficiency of clinical research through rationalisation of bureaucracy
https://doi.org/10.1136/esmoopen-2016-000100 ESMO - Magnitude of Clinical Benefit Scale V.1.0 questions and answers
https://doi.org/10.1136/esmoopen-2020-001051 Bratislava Statement: consensus recommendations for improving pancreatic cancer care
https://doi.org/10.1093/annonc/mdl073 Problems of opioid availability and accessibility across Europe: ESMO tackles the regulatory causes of intolerable and needless suffering
https://doi.org/10.1136/esmoopen-2019-000611 EHA evaluation of the ESMO—Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for haematological malignancies
https://doi.org/10.1136/esmoopen-2016-000107 Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO)
https://doi.org/10.1016/j.esmoop.2021.100237 Beyond the lessons learned from the COVID-19 pandemic: opportunities to optimize clinical trial implementation in oncology
https://doi.org/10.18332/ejm/142571 Accelerating the digital transformation of community midwifery during the COVID-19 pandemic
https://doi.org/10.1016/j.jcpo.2023.100438 European Cancer Organisation Essential Requirements for Quality Cancer Care: Adult glioma
https://doi.org/10.1016/j.annonc.2022.09.162 Streamlining clinical research: an ESMO awareness call to improve sponsoring and monitoring of clinical trials
https://doi.org/10.1016/j.ctrv.2021.102208 European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC): Pancreatic Cancer
https://doi.org/10.1016/j.annonc.2023.09.2643 1689O Comprehensive mapping review of real-world evidence publications focusing on targeted therapies in solid tumors: A collaborative work from ESMO real-world data and Digital Health Working Group
https://doi.org/10.1016/j.tjpad.2025.100098 Brain health services for the secondary prevention of cognitive impairment and dementia: Opportunities, challenges, and the business case for existing and future facilities
https://doi.org/10.1016/j.esmoop.2021.100219 Current landscape of ESMO/ASCO Global Curriculum adoption and medical oncology recognition: a global survey
https://doi.org/10.1136/jitc-2022-005732 Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries
https://doi.org/10.1038/s41598-023-29127-5 Outcomes of cystoid macular edema following Descemet’s membrane endothelial keratoplasty in a referral center for keratoplasty in Spain: retrospective study
https://doi.org/10.3233/shti230809 The Internet of Medical Things: Opportunities, Benefits, Challenges and Concerns
https://doi.org/10.1016/j.jacr.2020.05.024 Cumulative Radiation Dose From Medical Imaging in Children With Noncancerous Disease
https://doi.org/10.1200/go.21.00100 Toward Improved Outcomes for Patients With Lung Cancer Globally: The Essential Role of Radiology and Nuclear Medicine
https://doi.org/10.1186/s12967-022-03592-4 Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 2nd – 4th, 2021, Italy)
https://doi.org/10.3233/shti230130 MedSecurance Project: Advanced Security-for-Safety Assurance for Medical Device IoT (IoMT)
https://doi.org/10.1016/j.labinv.2024.102203 Annotation Practices in Computational Pathology: A European Society of Digital and Integrative Pathology (ESDIP) Survey Study
https://doi.org/10.1111/dth.14445 “Two wavelengths endovaginal laser system”: Clinical evaluation of a new device for mild SUI and vaginal atrophy treatment
https://doi.org/10.1016/j.esmoop.2021.100373 WHO-ESMO collaboration in cancer control: policies into action to save lives
https://doi.org/10.1016/j.jval.2022.09.2366 RWD141 Exploration of Melanoma Patient-Generated Real-World Data Using an Ai-Based Social Listening Approach
https://doi.org/10.3390/jmahp12030011 The Role of Medical Societies and the Relevance of Clinical Perspective in the Evolving EU HTA Process: Insights Generated at the 2023 Fall Convention and Survey of the European Access Academy
https://doi.org/10.1016/j.annonc.2025.07.017 Updated treatment recommendations for systemic treatment: from the ESMO Metastatic Breast Cancer Living Guideline
https://doi.org/10.1080/15583058.2022.2108354 On the Stability of Underground Masonry Vaults: The Case of the Mairie d’Ivry Station of the Paris Metro
https://doi.org/10.1097/op9.0000000000000048 Protecting the health care workforce from cytotoxic drugs contamination in the hospital wards: the results of the pan-European MASHA-2 project
https://doi.org/10.1016/j.ejcped.2024.100163 SIOPE and ESOP recommendations for extemporaneous compounding of oral liquid medicine formulations in paediatric oncology
https://doi.org/10.1016/j.esmoop.2022.100622 ESMO Designated Centres of Integrated Oncology and Palliative Care (ESMO DCs): education, research and programme development survey
https://doi.org/10.1016/j.esmoop.2025.105125 Pan-Asia adapted ESMO Clinical Practice Guideline for the management of patients with newly diagnosed and relapsed epithelial ovarian cancer
https://doi.org/10.1136/bmjopen-2025-107946 Improving communication to enhance health literacy and self-management of heart failure: protocol for a multimethod study
https://doi.org/10.1038/s41591-025-04055-1 Reduce bureaucracy in clinical trials now
https://doi.org/10.1016/j.esmoop.2025.106019 ESMO Clinical Practice Guideline Express Update on the adoption of physical exercise in patients with localised colon cancer
https://doi.org/10.1093/annonc/mdq205 Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
https://doi.org/10.1097/opx.0000000000000321 Autofluorescence Patterns as a Predictive Factor for Neovascularization
https://doi.org/10.1016/j.critrevonc.2019.07.007 ECCO Essential Requirements for Quality Cancer Care: Primary care
https://doi.org/10.5455/aim.2019.27.341-347 Data Sources and Gateways: Design and Open Specification
https://doi.org/10.1016/j.esmoop.2021.100362 Prioritising systemic cancer therapies applying ESMO’s tools and other resources to assist in improving cancer care globally: the Kazakh experience
https://doi.org/10.5455/aim.2019.27.355-361 Interoperability Techniques in CrowdHEALTH project: The Terminology Service
https://doi.org/10.1136/esmoopen-2020-000743 Application of the ESMO-Magnitude of Clinical Benefit Scale (V.1.1) to the field of early breast cancer therapies
https://doi.org/10.1016/j.esmoop.2021.100123 The systemic pro-inflammatory response: targeting the dangerous liaison between COVID-19 and cancer
https://doi.org/10.1200/cci.21.00177 Establishment of CORONET, COVID-19 Risk in Oncology Evaluation Tool, to Identify Patients With Cancer at Low Versus High Risk of Severe Complications of COVID-19 Disease On Presentation to Hospital
https://doi.org/10.5455/aim.2019.27.333-340 The Integrated Holistic Security and Privacy Framework Deployed in CrowdHEALTH Project
https://doi.org/10.5455/aim.2019.27.362-368 Generating and Knowledge Framework: Design and Open Specification
https://doi.org/10.5455/aim.2019.27.348-354 Disseminating Research Outputs: The CrowdHEALTH Project
https://doi.org/10.1136/bmjopen-2021-051181 Use of information and communication technologies (ICTs) in cancer multidisciplinary team meetings: an explorative study based on EU healthcare professionals
https://doi.org/10.2196/45563 The Impact of COVID-19 and Exposure to Violent Media Content on Cyber Violence Victimization Among Adolescents in South Korea: National Population-Based Study
https://doi.org/10.1111/aos.15211 Acute corneal allograft rejection following SARS‐CoV‐2 vaccination–A systematic review
https://doi.org/10.1136/esmoopen-2016-000114 Quality to rely on: meeting report of the 5th Meeting of External Quality Assessment, Naples 2016
https://doi.org/10.2196/48393 Sharing Digital Health Educational Resources in a One-Stop Shop Portal: Tutorial on the Catalog and Index of Digital Health Teaching Resources (CIDHR) Semantic Search Engine
https://doi.org/10.1016/j.esmoop.2024.103618 An assessment of the attitudes, knowledge, and education regarding the health care needs of LGBTQ patients with cancer: results of an ESMO/SIOPE global survey
https://doi.org/10.3390/healthcare12202041 Progress Achieved, Landmarks, and Future Concerns in Biomedical and Health Informatics
https://doi.org/10.1093/annonc/mdn115 Differentiated thyroid cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
https://doi.org/10.1093/annonc/mdi820 ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of newly diagnosed large cell non-Hodgkin's lymphoma
https://doi.org/10.1093/annonc/mdw239 ESMO/ASCO recommendations for a Global Curriculum (GC) in medical oncology—edition 2016
https://doi.org/10.1093/annonc/mdl164 Introduction: ASCO-ESMO consensus statement on quality cancer care
https://doi.org/10.1136/esmoopen-2015-000030 Back to the ‘essence’ of medical treatment in oncology: the 2015 WHO Model List of Essential Medicines
https://doi.org/10.1200/jco.2006.07.4328 Introduction: ASCO-ESMO Consensus Statement on Quality Cancer Care
https://doi.org/10.1136/esmoopen-2019-000615 Old drug, new clinical use, no man’s land for the indication: an awareness call from European experts
https://doi.org/10.1136/esmoopen-2020-000681 Lessons learnt from scoring adjuvant colon cancer trials and meta-analyses using the ESMO-Magnitude of Clinical Benefit Scale V.1.1
https://doi.org/10.1136/esmoopen-2018-000420 Preparing for the incoming wave of biosimilars in oncology
https://doi.org/10.3233/978-1-61499-959-1-255 CrowdHEALTH: Big Data Analytics and Holistic Health Records
https://doi.org/10.5220/0009388802410249 CrowdHEALTH: An e-Health Big Data Driven Platform towards Public Health Policies
https://doi.org/10.1136/ijgc-2021-esgo.351 184 UPLIFT (ENGOT-ov67/GOG-3048) a pivotal cohort of upifitamab rilsodotin, a NaPi2b-directed ADC in platinum-resistant ovarian cancer
https://doi.org/10.1016/s2352-3026(22)00254-x Control participants of randomised trials: an often forgotten, vulnerable population
https://doi.org/10.1016/j.annonc.2023.12.009 Current strategies of cell and gene therapy for solid tumors: results of the joint international ESMO and CTIWP-EBMT survey
https://doi.org/10.1002/jpn3.12136 Anthropometric assessment: ESPGHAN quality of care survey from paediatric hospitals in 28 European countries
https://doi.org/10.1093/annonc/mdl259 Brain tumors: molecular biology and targeted therapies
https://doi.org/10.1093/annonc/mdn106 Erythropoietins in cancer patients: ESMO Recommendations for use
https://doi.org/10.1023/a:1017409423484 ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cancers of unknown primary site (CUP)
https://doi.org/10.1093/annonc/mdg421 Continuing medical education: a must for every medical oncologist
https://doi.org/10.1093/annonc/mdv154 An ESMO-EORTC position paper on the EU clinical trials regulation and EMA's transparency policy: making European research more competitive again
https://doi.org/10.1136/bmjspcare-2014-000835 Systematic bias in cancer patient-reported outcomes: symptom ‘orphans’ and ‘champions’
https://doi.org/10.1016/s1470-2045(19)30248-7 Shortages of inexpensive essential medicines
https://doi.org/10.1158/1078-0432.ccr-19-3136 Design and Conduct of Early Clinical Studies of Immunotherapy: Recommendations from the Task Force on Methodology for the Development of Innovative Cancer Therapies 2019 (MDICT)
https://doi.org/10.1177/1078155209347402 Docetaxel combined with oral etoposide as second-line treatment for advanced gastric carcinoma after failure of platinum- and fluoropyrimidine-based regimens
https://doi.org/10.5455/aim.2020.28.52-57 Advanced Interoperability Techniques: Structure Mapping Service in CrowdHEALTH Project
https://doi.org/10.1136/esmoopen-2019-000628 Current models, challenges and best practices for work conducted between European academic cooperative groups and industry
https://doi.org/10.1016/j.esmoop.2023.101566 COVID-19 in cancer patients: update from the joint analysis of the ESMO-CoCARE, BSMO, and PSMO international databases
https://doi.org/10.1002/cncr.29261 Critical evaluation of the scientific content in clinical practice guidelines